FDA Approved: SPIRONOLACTONE — Supplemental Application (Oxford Pharmaceuticals, LLC)

View source ↗

Summary

The FDA approved a supplemental application for spironolactone from Oxford Pharmaceuticals, LLC, under the existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis with Ascites
• Heart Failure
• Hyperaldosteronism
• Hypertension

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

SUPPL AP for SPIRONOLACTONE (SPIRONOLACTONE)